New

CTRS is now ISO 9001:2015 & ISO 27001:2022 certified — View certificates

CTRS Training: new batch enrolling, with a paid internship — Learn more

Planning a Phase II–IV study? Get a free feasibility consultation — Talk to an expert

Therapeutic Areas

Therapeutic solutions

Advancing healthcare through innovative therapeutic research, development and delivery of life-changing treatments across multiple disease areas.

Therapeutic Areas
ISO 9001 & 27001 Certified
Specialised Expertise

Deep expertise across diverse therapeutic areas

Our experienced team brings specialised knowledge to every study, whatever the indication.

Orthopaedics

Bone, joint and musculoskeletal conditions, from arthritis to post-surgical recovery.

Oncology

Solid tumours and haematological malignancies, from targeted therapy to supportive care.

Cardiovascular

Heart and vascular disease research, from prevention to advanced procedures.

Central Nervous System

Neurological and psychiatric studies for breakthrough treatments.

Respiratory

Pulmonary diseases and respiratory conditions research.

Endocrinology & Metabolic

Diabetes, obesity and hormonal disorders.

Infectious Diseases

Bacterial, viral and parasitic infections and vaccine innovation.

Immunology & Autoimmune

Immune system and autoimmune disorder research.

Dermatology

Skin conditions and dermatological treatments.

Gastroenterology

Digestive system and hepatic disorders.

Ophthalmology

Eye diseases and vision research.

Haematology

Blood disorders and their treatments.

Rare Diseases & Paediatrics

Orphan drugs, child and newborn health studies.

Women's Health

Gender-specific healthcare research.

General Medicine

Common adult conditions and chronic disease management.

Dental & Oral Health

Oral health, dental treatments and preventive care.

Therapeutic & Study Portfolio

Diverse expertise. Deeper impact.

How our clinical study portfolio is spread across therapeutic areas and trial phases.

Therapeutic AreasShare of studies
  • Orthopaedics30%
  • Cardiology20%
  • Endocrinology18%
  • Dermatology12%
  • Gastroenterology10%
  • Others10%
Study Portfolio by PhaseShare of studies
  • Phase II15%
  • Phase III50%
  • Phase IV35%

Half of our portfolio is pivotal Phase III research, supported by strong Phase IV post-marketing experience.

Research Infrastructure

Methodologies supporting breakthrough development

Drug Discovery & Development

Identifying and developing new therapeutic compounds with enhanced efficacy and safety profiles.

  • Compound library screening
  • Lead optimisation
  • Pharmacokinetic studies
  • Toxicology assessment

Clinical Research Management

Comprehensive trial management ensuring regulatory compliance and patient safety.

  • Protocol development
  • Patient recruitment
  • Data management
  • Statistical analysis

Regulatory Affairs & Compliance

Expert guidance through approval processes so therapeutic products meet stringent requirements.

  • Regulatory submissions
  • Regulatory strategy
  • Quality assurance
  • Compliance monitoring

Precision Medicine & Biomarkers

Personalised approaches based on genetic profiles and biomarkers for optimal outcomes.

  • Genomic analysis
  • Biomarker discovery
  • Personalised protocols
  • Companion diagnostics
Clinical scientist
Quality & Regulatory Excellence

Uncompromising standards for patient safety

Every study is conducted with meticulous attention to patient safety and scientific integrity.

  • Compliant research processes aligned with global regulators
  • Comprehensive quality assurance and control protocols
  • International regulatory expertise and submissions
  • Real-time patient safety monitoring
  • Independent ethics committee oversight
  • Continuous staff training and certification

Don't see your therapeutic area?

Our experienced team has conducted trials across many additional therapeutic areas. Contact us to discuss your specific research needs.

+91-9828676917 · Mon–Fri, 9AM–6PM